LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ROL
Rollins, Inc.
ROL has the edge over LCID overall, supported by lower modeled downside and stronger valuation.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ROL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
ROL's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ROL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $37.91 | — |
| Current | 35x | $37.91 | — |
| Cheap | 48x | $52.17 | +38% |
| Fair | 53x | $57.70 | +52% |
| Expensive | 60x | $65.31 | +72% |
Historical ranges are pointers, not guarantees.
ROL's PE is in its cheap range at 35x. On analysts' estimates for next year's earnings, today's price would be 31x.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ROL Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect ROL's revenue to grow, but its profitability to weaken.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ROL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.20 | +11% |
| Q3 2026 | $1.09 | +1.9% |
| Q2 2026 | $1.10 | +8.9% |
| Q1 2026 | $1.09 | +10% |
| Q4 2025 | $1.09 | +14% |
| Q3 2025 | $1.07 | +10% |
| Q2 2025 | $1.01 | +6.3% |
| Q1 2025 | $0.99 | +10% |
| Q4 2024 | $0.96 | +7.9% |
ROL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ROL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ROL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +6.2% |
| Q2 2026 | $1.1B | +7.9% |
| Q1 2026 | $906.4M | +10% |
| Q4 2025 | $912.9M | +9.7% |
| Q3 2025 | $1B | +12% |
| Q2 2025 | $999.5M | +12% |
| Q1 2025 | $822.5M | +9.9% |
| Q4 2024 | $832.2M | +10% |
ROL's revenue has grown year over year every quarter since late 2020: $1.1B last quarter, up 6.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -1.5 points |
| Q2 2026 | 19% | -1.2 points |
| Q1 2026 | 16% | -1.3 points |
| Q4 2025 | 18% | -0.6 points |
| Q3 2025 | 22% | +1 points |
| Q2 2025 | 20% | -0.6 points |
| Q1 2025 | 17% | -0.4 points |
| Q4 2024 | 18% | -0.3 points |
ROL has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ROL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $235.5M | +29% |
| Q2 2026 | $166.1M | -1.2% |
| Q1 2026 | $111.2M | -21% |
| Q4 2025 | $159M | -14% |
| Q3 2025 | $182.8M | +31% |
| Q2 2025 | $168M | +23% |
| Q1 2025 | $140.1M | +17% |
| Q4 2024 | $184M | +30% |
ROL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
ROL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -2.4M shares |
| 1 year | -1.2% | -5.7M shares |
| 3 years | -2.4% | -12M shares |
| 5 years | -2.7% | -13.1M shares |
| Available history | -2.5% | -12.2M shares |
ROL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $120.1M |
| Q2 2026 | $20M |
| Q1 2026 | $22.4M |
| Q4 2025 | $198.3M |
| Q3 2025 | $3.7M |
| Q2 2025 | $251,000 |
| Q1 2025 | $14.7M |
| Q4 2024 | $72,000 |
ROL spent $361M buying back its own shares over the past year, more than ten times what it spent the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ROL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.7x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.4x | Very low |
| Q4 2024 | 0.4x | Very low |
ROL's net debt is less than a year of its operating earnings (EBITDA).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ROL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 72.8 | Neutral |
ROL's weekly RSI is 45 (neutral) and its Stochastic is 73 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ROL PE vs Consumer Cyclical Sector
| Metric | ROL | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 18x | 93% above |
| PE % | 4 | 47 | 43 pts below |
ROL is trading at 35x earnings, a 93% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ROL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $33.9 | 12% above |
| 20 week MA | $36.5 | 3.7% above |
| 50 week MA | $48.2 | 21% below |
| 100 week MA | $51.5 | 26% below |
| 200 week MA | $47.3 | 20% below |
ROL has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
ROL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.8 | $40.1 | +84% |
| 2021 | $40.1 | $32.8 | -18% |
| 2022 | $32.8 | $37.1 | +13% |
| 2023 | $37.1 | $43.7 | +18% |
| 2024 | $43.7 | $46.7 | +6.9% |
| 2025 | $46.7 | $60.6 | +30% |
| 2026 YTD | $60.6 | $37.9 | -37% |
ROL has the edge over LCID on returns for 2026, with the stronger performance.